Early Intervention in High Risk CCUS — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Intervention in High Risk CCUS — Stella

Home/Clonal Cytopenia of Undetermined Significance/

View on ClinicalTrials.gov

Recruiting

Back to Clonal Cytopenia of Undetermined Significance trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Dana-Farber Cancer Institute, Boston, Massachusetts

Key details

Phase

Very early testing

Sponsor

Lachelle D. Weeks, MD, PhD

Collaborators

Astex Pharmaceuticals, Inc., Break Through Cancer

Enrollment target

~108 participants

Started

February 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.